LENZ Therapeutics, Inc. (LENZ)
5.085
-0.12
(-2.40%)
USD |
NASDAQ |
Sep 01, 14:54
LENZ Therapeutics Total Long Term Debt (Quarterly) : 0.122M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.122M |
| March 31, 2026 | 0.237M |
| December 31, 2025 | 0.35M |
| September 30, 2025 | 0.461M |
| June 30, 2025 | 0.569M |
| March 31, 2025 | 0.673M |
| December 31, 2024 | 0.814M |
| September 30, 2024 | 0.953M |
| June 30, 2024 | 1.052M |
| March 31, 2024 | 0.156M |
| December 31, 2023 | 0.192M |
| September 30, 2023 | 49.67M |
| June 30, 2023 | 50.63M |
| Date | Value |
|---|---|
| March 31, 2023 | 1.419M |
| December 31, 2022 | 1.749M |
| September 30, 2022 | 2.451M |
| June 30, 2022 | 3.262M |
| March 31, 2022 | 4.542M |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 4.684M |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Ocular Therapeutix, Inc. | 76.26M |
| Enveric Biosciences, Inc. | 0.00 |
| Liquidia Corp. | 182.90M |
| Aquestive Therapeutics, Inc. | 148.26M |
| Impact BioMedical, Inc. | 0.00 |